Supplementary Materials for Fiscal Year Ended September 2026

Overview of Results

For the fiscal year ended September 2026, revenue was 43,455 hundred million yen, up +5.6% year-on-year, and operating income was 5,176 hundred million yen, up +8.2% year-on-year, achieving profit growth exceeding the Growth Next 2027 plan. Although the Cosmetics segment fell short of plan in certain respects, company-wide revenue increased driven by solid Healthcare growth and the effects of investments in Fun and Health. Marketing investments were reallocated with emphasis on ROI, and strengthening growth brands was the primary driver.

Outlook and Mid-term Plan Direction

The full-year plan for the fiscal year ending September 2027 assumes revenue of 46,000 hundred million yen and operating income of 5,400 hundred million yen. The company will continue growth investments in the Healthcare domain and aim to accelerate Fun and Health. Conversely, a reallocation of advertising investment for PERFECT ONE is expected to constrain growth in Cosmetics. Under the Growth Next 2027 mid-term management plan, expanding the Healthcare foundation is the top priority, and the company plans to expand the portfolio through new brand development and M&A.